Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Trying to decide which is better: cash back or points credit cards? Analyze your spending habits to make the best choice for maximizing rewards.
27,088 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A single fund's exit from Klaviyo set off a ripple effect that shaved a chunk from the stock after earnings. This art...
Companies are ditching token-based performance dashboards as ROI from AI pivots to concrete business outcomes like re...
I’ve spent week world’s top AI talks and the takeaway is sharp: talent battles and new pricing models will ripple thr...
A high-profile birthday surprise spotlighting an IMAX screening offers more than awe—it offers a practical lesson in ...
Bank of America upgrades FedEx to its US 1 List, signaling confidence in the company’s DRIVE plan and a stabilizing l...
A high-profile case highlights how private money moves can affect finances and risk. This article breaks down what yo...
Power Solutions International posted a softer-than-expected Q1 2026, with revenue miss and shrinking margins. Data-ce...
A major investment manager recently disclosed a sizable position in Varonis Systems. This article unpacks what the mo...
Bank Of America boosts its Affirm Holdings target to $88 after a solid quarter, framing May 12 investor day as a cata...
A tiny AI-focused company has surged roughly 4,000% while still welcoming retail investors. Here’s what’s driving the...
A private moment at a public arena can reveal more than gossip. This article uses the leaked taylor swift travis mome...